Managing sleep issues to control high blood pressure
Impact of Sleep-Disordered Breathing Management in Systemic Hypertension Control: METASLEEP Project
Sociedad Española de Neumología y Cirugía Torácica · NCT05986487
This study tests whether helping people with sleep problems can improve blood pressure control for those with high blood pressure.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 1523 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Sociedad Española de Neumología y Cirugía Torácica (other) |
| Locations | 1 site (Lleida) |
| Trial ID | NCT05986487 on ClinicalTrials.gov |
What this trial studies
This project focuses on improving hypertension management by integrating the monitoring and treatment of sleep-disordered breathing in primary care settings. It aims to implement a new system that combines 24-hour ambulatory blood pressure monitoring with sleep studies to enhance blood pressure control. The approach emphasizes personalized care and coordination between primary care teams and hypertension specialists to address the complexities of managing hypertension effectively. By recognizing sleep disturbances as a significant factor in hypertension, the study seeks to improve patient outcomes through a comprehensive evaluation and tailored interventions.
Who should consider this trial
Good fit: Ideal candidates are patients with arterial hypertension who are visiting their primary care physician.
Not a fit: Patients with previous diagnoses of obstructive sleep apnea or other sleep disorders, as well as those currently on CPAP treatment, may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could lead to better blood pressure control and reduced cardiovascular risks for patients with hypertension.
How similar studies have performed: Other studies have shown promising results in managing hypertension through integrated care approaches, suggesting that this method could be effective.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients with arterial hypertension who visit their primary care physician in one of the participating primary care centers. * Signature of the informed consent. Exclusion Criteria: * Psycho-physical inability to complete questionnaires. * Patients with very limiting chronic disease. * Previous diagnosis of OSA or any other sleeping disorder * Active treatment with CPAP. * Fixed night shift worker.
Where this trial is running
Lleida
- Hospital Universitari Arnau de Vilanova — Lleida, Spain (RECRUITING)
Study contacts
- Principal investigator: Ferran Barbé Illa, MD — Spanish Respiratory Society (SEPAR)
- Study coordinator: Ferran Barbé Illa, MD
- Email: febarbe.lleida.ics@gencat.cat
- Phone: +34 973705372
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Hypertension, Obstructive Sleep Apnea